معرفی
Jeffrey P. Kahn is the Robert Henry Levi and Ryda Hecht Levi Professor at Johns Hopkins University, with a primary appointment in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. He is a core faculty member at the Johns Hopkins Berman Institute of Bioethics, where he leads research on the ethical, legal, and social implications of emerging biomedical technologies.
- PhD, Georgetown University, 1989
- MPH, Johns Hopkins Bloomberg School of Public Health, 1988
Dr. Kahn’s research focuses on bioethics and public health, with particular expertise in ethics and genomics, research ethics, science policy, and the governance of digital health technologies. His work addresses critical questions about informed consent, equity in access to genomic medicine, public trust in biobanking, and the ethical use of data in public health surveillance. He has led major initiatives such as the Genomic Uses in Infectious Diseases and Epidemics (GUIDE) project and research on digital contact tracing governance.
His recent publications reveal a strong trend toward interdisciplinary scholarship, integrating insights from law, policy, history, and social sciences to address complex challenges at the intersection of genetics, infectious diseases, and public health. Themes include anticipatory governance of genome editing, regulatory innovation for rare diseases, and ethical frameworks for decentralized biobanking and digital health applications.
- Member, Delta Omega Honorary Society in Public Health, Alpha Chapter (Johns Hopkins Bloomberg School of Public Health), 2014
- Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy, 2011–present
Dr. Kahn has mentored numerous scholars and contributed to national and international policy discussions on bioethics. He has received continuous research funding for projects exploring the ethical dimensions of biobanking, genomic surveillance, and public engagement in science. His leadership extends to collaborative networks such as the BRIDGES Collaboratory, which advances ethical, legal, and social studies at the nexus of infectious and genetic diseases.
He is actively involved in research centers including the Johns Hopkins Berman Institute of Bioethics and leads projects that integrate ethics into public health practice and policy development.
